Bleeding risk with clopidogrel and percutaneous endoscopic gastrostomy

查看全文 作　　者：Umair [1]Sohail;Chela [1]Harleen;Amin O [1]Mahdi;Murtaza [1]Arif;Douglas L [2]Nguyen;Matthew L [1]Bechtold

机构地区：[1]Division of Gastroenterology and Hepatology, Department of Medicine, University of Missouri;[2]Department of Medicine, University of California

出　　处：《World Journal of Gastrointestinal Endoscopy》索引2016年第8卷第16期,共5页

摘　　要：AIM To compare bleeding within 48 h in patients undergoing percutaneous endoscopic gastrostomy(PEG) with or without clopidogrel.METHODS After institutional review board approval, a retrospective study involving a single center was conducted on adult patients having PEG(1/08-1/14). Patients were divided into two groups: Clopidogrel group consisting of those patients taking clopidogrel within 5 d of PEG and the non-clopidogrel group including those patients not taking clopidogrel within 5 d of the PEG.RESULTS Three hundred and nineteen PEG patients were found. One hundred and sixty-eight males and 151 females with mean body mass index 28.47 ± 9.75 kg/m2 and mean age 65.03 ± 16.11 years were identified. Thirtythree patients were on clopidogrel prior to PEG with 286 patients not on clopidogrel. No patients in either group developed hematochezia, melena, or hematemesiswithin 48 h of percutaneous endoscopic gastrostomy(PEG). No statistical differences were observed between the two groups with 48 h for hemoglobin decrease of > 2 g/dL(2 vs 5 patients; P = 0.16), blood transfusions(2 vs 7 patients; P = 0.24), and repeat endoscopy for possible gastrointestinal bleeding(no patients in either group). CONCLUSION Based on the results, no significant post-procedure bleeding was observed in patients undergoing PEG with recent use of clopidogrel. 关键词：PERCUTANEOUS endoscopic GASTROSTOMY CLOPIDOGREL BLEEDING COMPLICATIONS ANTIPLATELETS

相关文献

参考文献（18）
引证文献（2）
耦合文献（0）

参考文献(18)

引证文献(2)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Bleeding risk with clopidogrel and percutaneous endoscopic gastrostomy

参考文献(18)

引证文献(2)

用户提示